Revelations Biotech

Hyderabad, India Founded: 2008 • Age: 18 yrs
Solutions for enzymes, prebiotics, probiotics, and functional ingredients are developed.
Annual revenue $1.3M Latest available
Total funding $2.5M 3 rounds
Employees 47 Tracked headcount
Investors 16 Known backers
Products 4 Services tracked
Competitors 10 Brand Intelligence

About Revelations Biotech

Revelations Biotech is a company based in Hyderabad (India) founded in 2008 by Ravi Chandra Beeram. Revelations Biotech has raised $2.5 million across 3 funding rounds from investors including Narla Family Living Trust, Onest Investors and Evolve Venture Capital. The company has 47 employees as of April 07, 2024. Revelations Biotech offers products and services including FOSLIFE, FOSGRO TM, Probiotics, and Enzymes. Revelations Biotech operates in a competitive market with competitors including Charles River Laboratories, Avidity Biosciences, Cytel, Univercells and Sutro Biopharma, among others.

  • Headquarter Hyderabad, India
  • Employees 47 as on 07 Apr, 2024
  • Founders Ravi Chandra Beeram
  • Stage Minicorn
  • Sectors
    Consumer
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Revelations Biotech Private Limited
  • Date of Incorporation 15 Oct, 2008
  • Jurisdiction Hyderabad, Telangana, India
Operational Areas
Consumer → Food, Beverage & Nutrition Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.34 M (USD)
    38.03
    as on Mar 31, 2023
  • Net Profit
    $140.82 K (USD)
    -21.97
    as on Mar 31, 2023
  • EBITDA
    $216.64 K (USD)
    -9.84
    as on Mar 31, 2023
  • Total Equity Funding
    $2.5 M (USD)

    in 3 rounds

  • Latest Funding Round
    $1.9 M (USD), Seed

    Oct 16, 2023

  • Investors
  • Employee Count
    47

    as on Apr 07, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Revelations Biotech

Revelations Biotech offers a comprehensive portfolio of products and services, including FOSLIFE, FOSGRO TM, Probiotics, and Enzymes.

Product name locked
Category locked
Primary

Prebiotic product enhancing gut health and dietary fiber

Product name locked
Category locked
Locked

Enzyme for sugar reduction in food and beverages

Product name locked
Category locked
Locked

Probiotics supporting overall health and wellness

Product name locked
Category locked
Locked

Enzymes for applications in food, feed, and pharmaceuticals

Funding Insights of Revelations Biotech

Revelations Biotech has successfully raised a total of $2.5M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $1.9 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Revelations Biotech

Revelations Biotech has secured backing from 16 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Narla Family Living Trust, Onest Investors and Evolve Venture Capital.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
A venture capital firm focused on tech startup growth.
Locked Locked Locked
-
Locked Locked Locked

Venkata Subba Rao Chunduru

-
Locked Locked Locked
Premium access

Investor details for Revelations Biotech

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Revelations Biotech

Investments
Premium access

Investment portfolio details for Revelations Biotech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Revelations Biotech

Premium access

Detailed financials for Revelations Biotech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Revelations Biotech Comparisons

Revelations Biotech Primary company
Description
Solutions for enzymes, prebiotics, probiotics, and functiona...
Location
Hyderabad, India
Founded Year
2008
Annual Revenue
$1.34 M (USD)
Net Profit
$140.82 K (USD)
EBITDA
$216.64 K (USD)
Employees
47
As of 2024
Premium access

Peer comparison for Revelations Biotech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Revelations Biotech

Revelations Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Avidity Biosciences, Cytel, Univercells and Sutro Biopharma, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of drug discovery and preclinical development services
Locked Locked Locked
Antibody-siRNA complexes are developed for cancer treatment.
Locked Locked Locked
Data analysis and statistical solutions are provided for life sciences.
Locked Locked Locked
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
Locked Locked Locked
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
Locked Locked Locked
Developing novel drugs based on a proteome-wide ligand and target discovery platform
Premium access

Detailed competitors of Revelations Biotech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Revelations Biotech

Premium access

Complete news archive for Revelations Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Revelations Biotech

Revelations Biotech was founded in 2008 and raised its 1st funding round 8 years after it was founded.

Revelations Biotech is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Revelations Biotech is a funded company, having raised a total of $2.5M across 3 funding rounds to date.

As of Apr 07, 2024, the latest employee count at Revelations Biotech is 47.

Annual revenue of Revelations Biotech is $1.34M as on Mar 31, 2023.

Provider of solutions for delopment of enzymes, prebiotics, probiotics and functional ingredients. It offers FOSLIF Fructooligosaccharides prebiotic sweeteners for food and nutraceutical use, FOSGRO animal feed prebiotic promoting gut health and growth in livestock, aquaculture, and pets by supporting beneficial gut bacteria, microbial strains and enzymes for food, feed, and industrial applications.

Revelations Biotech's top competitors include Sutro Biopharma, Avidity Biosciences and Vividion Therapeutics.

Revelations Biotech offers FOSLIFE, FOSGRO TM, Probiotics, and Enzymes.

Revelations Biotech has 16 investors. Key investors include Narla Family Living Trust, Onest Investors, Evolve Venture Capital, Resilient And Financial Consulting, and Foraysoft.

The valuation of Revelations Biotech is $50.09M as of Oct 2023.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available